(Q33921751)

30 July 2017

1 reference

https://doi.org/10.1002/14651858.CD000410.pub2

1 reference

29 December 2023

title

Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. (English)

1 reference

polycystic ovary syndrome

30 July 2017

main subject

1 reference

1 reference

D Nugent

1

1 reference

30 July 2017

P Vandekerckhove

2

1 reference

30 July 2017

E Hughes

3

1 reference

30 July 2017

M Arnot

4

1 reference

30 July 2017

R Lilford

5

1 reference

30 July 2017

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

published in

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

CD000410

1 reference

Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000410

The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000410

Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000410

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000410

Psychological consequences of having triplets: a 4-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000410

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000410

Hypersecretion of luteinising hormone, infertility, and miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000410

Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Ovarian hyperstimulation syndrome: an update review.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Pulsatile Patterns of Gonadotropin Release in Subjects with and without Ovarian Function

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

LHRH analogues for ovulation induction, with particular reference to polycystic ovary syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

The luteal phase in polycystic ovary syndrome during ovulation induction with human menopausal gonadotropin with and without leuprolide acetate

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Treatment of anovulation in the Stein-Leventhal syndrome. Analysis of 90 cases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Treatment of anovulatory infertility: the problem of multiple pregnancy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Factors involved in the induction of fertile ovulation with human gonadotrophins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Failure of human oocyte release at ovulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Effects of LH suppression in polycystic ovary syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Ovarian Hyperstimulation Syndrome: A Current Survey

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

The initial experience with the use of a portable infusion pump in the delivery of human menopausal gonadotropins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Higher multiple births and the modern management of infertility in Britain. The British Association of Perinatal Medicine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Ovulation induction in polycystic ovarian disease by pure FSH (Metrodin). A comparison between chronic low-dose pulsatile administration and i.m. injections

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000410

Identifiers

DOI

10.1002/14651858.CD000410

1 reference

30 July 2017

1 reference